Efficacy and Safety of Anticoagulation with Edoxaban in Patients with AHRE Durations ≥24 Hours: The NOAH-AFNET 6 Trial
A prespecified subanalysis of the NOAH-AFNET 6 trial evaluated the efficacy and safety of edoxaban anticoagulation in patients with Atrial High-Rate Episodes (AHRE) lasting 24 hours compared to shorter episodes. Findings suggest that oral anticoagulation with edoxaban does not significantly reduce t
0 views • 13 slides
Advances in Anticoagulation Therapy for Cancer-Related VTE and Stroke
Recent studies have shown advancements in anticoagulation therapy for cancer patients with venous thromboembolism (VTE) and stroke prevention. Direct oral anticoagulants (DOACs) are now considered beneficial for treating VTE in cancer, offering advantages in administration and efficacy. Different an
3 views • 9 slides
Understanding Anticoagulants and Their Indications
Explore the world of anticoagulants through images, covering different types like warfarin and NOACs, their indications such as AF, DVT, and PE, monitoring in clinics, and specific drug details like apixaban, rivaroxaban, dabigatran, and edoxaban. Get insights into dosages, administration, and drug
0 views • 27 slides